Global Fluorescent In Situ Hybridization Probe Market Snapshot to 2027 - North America Holds Major Market Share Due to High Incidence Rate of Genetic Disorders

Global Genome Engineering Market Report 2022: Rising Funding and Investments for Research and Development Present Lucrative Opportunities

company logo

company logo

Dublin, 08 Dec. 2022 (GLOBE NEWSWIRE) — The “Genome Engineering Market – Global Industry Size, Share, Trends, Opportunities and Forecast, 2017-2027 Segmented by Technology (CRISPR, TALEN, ZFN, Antisense, Others), By Delivery Method (Ex-Vivo v/s In-Vivo), By Application, By End User, By Region” has been added to the report from offer.

The global genome engineering market is expected to witness impressive growth over the forecast period. Genome engineering is a process that allows the insertion, deletion, modification or replacement of DNA into the genome of a living organism. Accordingly, the technique can be used for the development of new therapies, treatments and drugs for different therapeutic areas, especially chronic diseases.

Various academic and research institutions and biotechnology and pharmaceutical companies are focusing and using this technology for the development of new therapies. For example, Synthego Corporation launched the Clustered Regularly Spaced Short Palindromic Repeats (CRISPR) Pioneer Program in October 2017. Using these clustered regularly spaced short palindromic repeats, researchers are focused on finding cures for cancer and other diseases.

Increase the development of new technologies

Various companies and academic and research institutions use the technique of genome engineering for the development of new therapies and new treatments. It not only helps them to improvise their status but also improves the market positioning of various companies and helps them gain an edge over other players operating in the market. For example, Sangamo Therapeutics, Inc.’s SB-FIX, a zinc finger nuclease (ZFN)-mediated in vivo genome editing treatment for hemophilia B, has received clinical trial authorization (CTA) from the UK Medicines and Healthcare Products Regulatory Agency (MHRA) in February 2018. Similarly, the first variation of the Cas9 enzyme, which reduces off-target effects in CRISPR genome editing, was introduced in 2017 by Integrated DNA Technologies, Inc. This represented an important step towards the therapeutic application of CRISPR.

Increase funding and investments for research and development

Growing funding and investments in the study and development of new genetic engineering technologies are expected to create lucrative opportunities for the growth of the genome engineering market in the coming years. For example, the US National Institutes of Health (NIH) said in January 2018 that it would support genome editing research through its new program called Somatic Cell Genome Editing. Under this program, grants will be awarded to researchers from Canada and the United States to conduct research related to genome editing.

Growing application areas of genomics

The applications of genomics have increased significantly over the years in different fields including forensics, genetic disorders, drug discovery, agriculture, among others. The advent of next-generation sequencing has increased the application of genomics in forensic fields. Future trends in genome engineering include its application in the field of nutraceuticals, marine engineering, among others. Personalized nutrition and precision medicine is another area where the demand for genome engineering is expected to increase. Many researches and clinical trials are being conducted in different parts of the world to identify more areas where genome engineering is used. This, in turn, will create lucrative opportunities for the growth of the Global Genome Engineering Market over the coming years.

Report Scope:

In this report, the global genome engineering market has been segmented into the following categories, in addition to industry trends which have also been detailed below:

Genome Engineering Market, By Technology:



  • ZFN

  • Antisense

  • Others

Genome Engineering Market, By Delivery Mode:

Genome Engineering Market, By Application:

Genome Engineering Market, By End User:

Genome Engineering Market, By Region:

  • North America

  • United States

  • Canada

  • Mexico

  • Europe

  • Germany

  • France

  • UK

  • Spain

  • Italy

  • Asia Pacific

  • China

  • India

  • Japan

  • South Korea

  • Australia

  • South America

  • Brazil

  • Argentina

  • Colombia

  • Middle East and Africa

  • South Africa

  • Saudi Arabia

  • United Arab Emirates

Main topics covered:

1. Product introduction

2. Research methodology

3. Executive Summary

4. Impact of COVID-19 on the Global Genome Engineering Market

5. Voice of the customer

6. Global Genome Engineering Market Outlook

7. North America Genome Engineering Market Outlook

8. Europe Genome Engineering Market Outlook

9. Asia-Pacific Genome Engineering Market Outlook

10. South America Genome Engineering Market Outlook

11. Middle East & Africa Genome Engineering Market Outlook

12. Market dynamics

13. Market trends and developments

14. Porter’s Five Forces Analysis

15. PESTLE Analysis

16. Competitive landscape (including SWOT analysis of profiled players)

17. Strategic Recommendations

Companies cited

  • Merck KGaA

  • Sangamo Therapeutics, Inc.

  • Genscript Biotech Corporation

  • CRISPR Therapeutics SA

  • Published Medicine, Inc.

  • Precision BioSciences, Inc.

  • Horizon Discovery Group plc

  • Lonza Group Ltd.

  • OriGene Technologies, Inc.

  • Transposagen Biopharmaceuticals, Inc.

For more information about this report visit

CONTACT: CONTACT: Laura Wood,Senior Press Manager For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

#Global #Genome #Engineering #Market #Report #Rising #Funding #Investments #Research #Development #Present #Lucrative #Opportunities

Leave a Comment

Your email address will not be published. Required fields are marked *